Revance Therapeutics, Inc. (48) | Business Operations (7)
Browse by Subcategory
Recent Contracts
-
Technology Transfer, Validation and Commercial Fill/Finish Services Agreement dated March 14, 2017 between Revance Therapeutics, Inc. and Ajinomoto Althea, Inc
(Filed With SEC on February 28, 2022)
-
Commercial Supply Agreement, effective as of April 6, 2021, by and between Revance Therapeutics, Inc. and Lyophilization Services of New England, Inc
(Filed With SEC on August 5, 2021)
-
First Amendment to Exclusive Distribution Agreement
(Filed With SEC on November 9, 2020)
-
Form of Voting Agreement by and between Revance Therapeutics, Inc. and each of the parties named in each agreement therein
(Filed With SEC on June 10, 2020)
-
Amendment #1 to the Collaboration and License Agreement dated August 22, 2019 between Revance Therapeutics, Inc. and Mylan Ireland Ltd
(Filed With SEC on November 4, 2019)
-
Amendment No. 1 to the Technology Transfer, Validation and Commercial Fill/Finish Services Agreement dated December 18, 2020 between Revance Therapeutics, Inc. and Ajinomoto...
(Filed With SEC on February 25, 2021)
-
Exclusive Distribution Agreement, dated January 10, 2020, by and between Revance Therapeutics, Inc. and Teoxane SA
(Filed With SEC on February 26, 2020)